Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Ritlecitinib is safe and may effectively treat alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

The scaffold effectively prevents melanoma relapse and aids wound healing.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Oral baricitinib is effective and safe for treating alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The technique effectively promotes hair growth in young men with androgenetic alopecia.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Anti-CD19 therapy may help treat SLE and NMOSD.

Both treatments for alopecia areata showed similar modest effectiveness.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Methotrexate plus prednisolone had the fewest serious side effects.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.